Using cancer cell lines genetically deficient in BRCA1 and/or PTEN and siRNA-mediated depletions, our study shows that PARG deficiency is neither synthetic lethal with BRCA1 nor with PTEN deficiency. This evidence concerns the gene PTEN and cancer.